These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6446382)

  • 1. Cefoperazone sodium: proceedings of the first international symposium, Boston, October, 1979.
    Clin Ther; 1980; 3(Spec Issue):1-208. PubMed ID: 6446382
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo microbiological evaluations of cefoperazone.
    Renzini G; Ravagnan G; Piccolomini R; Dainelli B; Comanducci A
    Clin Ther; 1980; 3(Spec Issue):139-44. PubMed ID: 6446388
    [No Abstract]   [Full Text] [Related]  

  • 3. Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin.
    Blandino G; Dubini F; Russo G; Cocuzza G
    Clin Ther; 1980; 3(Spec Issue):103-11. PubMed ID: 6446383
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro and in vivo antibacterial activity of cefoperazone.
    Mitsuhashi S; Minami S; Matsubara N; Yotsuji A; Kurashige S; Saikawa I
    Clin Ther; 1980; 3(Spec Issue):1-13. PubMed ID: 6446381
    [No Abstract]   [Full Text] [Related]  

  • 5. Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test.
    Thornsberry C; Baker CN; Barry AL; Jones RN
    Clin Ther; 1980; 3(Spec Issue):39-45. PubMed ID: 6446397
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbiological studies on cefoperazone.
    Kayser FH
    Clin Ther; 1980; 3(Spec Issue):24-33. PubMed ID: 6446395
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R; Gillett AP; Andrews JM
    Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
    Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative activity of cefoperazone against selected cephalosporinase-producing enteric bacteria.
    Chabbert YA; Collatz E
    Clin Ther; 1980; 3(Spec Issue):98-102. PubMed ID: 6446402
    [No Abstract]   [Full Text] [Related]  

  • 11. In-vitro antibacterial activity of cefoperazone, a piperazine cephalosporin.
    King A; Warren C; Shannon K; Phillips I
    J Antimicrob Chemother; 1981 Aug; 8(2):107-13. PubMed ID: 6456255
    [No Abstract]   [Full Text] [Related]  

  • 12. Regression analyses for cefoperazone on Mueller-Hinton agar and DST agar.
    Langmaack H; Daschner F
    Clin Ther; 1980; 3(Spec Issue):123-6. PubMed ID: 6446384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefoperazone against clinical isolates of Enterobacteriaceae, Pseudomonas and Staphylococcus.
    Olarte J
    Clin Ther; 1980; 3(Spec Issue):130-3. PubMed ID: 6446386
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cefoperazone--activity in vitro].
    Hejzlar M; Silarová J; Pellar T; Kittnar E; Hájková L; Janatová E; Stastná L; Kotasová M; Puchmayerová M
    Cesk Epidemiol Mikrobiol Imunol; 1983 Mar; 32(2):82-6. PubMed ID: 6220824
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates.
    Trabulsi LR; Pereira da Silva Almada N; Marques LR
    Clin Ther; 1980; 3(Spec Issue):145-8. PubMed ID: 6446390
    [No Abstract]   [Full Text] [Related]  

  • 16. High resistance to fourth-generation cephalosporins among clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases isolated in Portugal.
    Fernandes R; Gestoso A; Freitas JM; Santos P; Prudêncio C
    Int J Antimicrob Agents; 2009 Feb; 33(2):184-5. PubMed ID: 18926667
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993-2001.
    Boutiba-Ben Boubaker I; Ghozzi R; Ben Abdallah H; Mamlouk K; Kamoun A; Ben Redjeb S
    Clin Microbiol Infect; 2004 Jul; 10(7):665-7. PubMed ID: 15214883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living with ESBLs. Introduction.
    Cornaglia G; Garau J; Livermore DM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():1-2. PubMed ID: 18154523
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases.
    Sanders CC
    J Chemother; 1996 Feb; 8 Suppl 2():57-62. PubMed ID: 8738847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.